Virtue Capital Management LLC cut its stake in shares of MetLife, Inc. (NYSE:MET – Free Report) by 12.1% in the 3rd quarter, Holdings Channel.com reports. The fund owned 5,383 shares of the financial services provider’s stock after selling 742 shares during the period. Virtue Capital Management LLC’s holdings in MetLife were worth $444,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of the company. PFG Investments LLC raised its holdings in MetLife by 8.9% in the third quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider’s stock worth $525,000 after buying an additional 520 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of MetLife during the third quarter valued at approximately $2,960,000. Segall Bryant & Hamill LLC purchased a new position in MetLife in the 3rd quarter worth approximately $1,074,000. Legal & General Group Plc raised its holdings in MetLife by 5.4% in the 2nd quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider’s stock worth $371,993,000 after acquiring an additional 269,246 shares during the last quarter. Finally, AIA Group Ltd lifted its position in MetLife by 101.4% in the 3rd quarter. AIA Group Ltd now owns 13,539 shares of the financial services provider’s stock valued at $1,117,000 after acquiring an additional 6,818 shares in the last quarter. Institutional investors own 89.81% of the company’s stock.
MetLife Stock Down 1.7 %
MET opened at $80.33 on Thursday. The firm’s 50 day simple moving average is $83.78 and its two-hundred day simple moving average is $77.20. The company has a market capitalization of $55.62 billion, a PE ratio of 16.20, a PEG ratio of 0.78 and a beta of 1.06. MetLife, Inc. has a 1-year low of $64.61 and a 1-year high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Announces Dividend
Analyst Ratings Changes
A number of research firms have commented on MET. TD Cowen lifted their target price on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. Wells Fargo & Company lifted their price objective on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Piper Sandler upped their target price on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Jefferies Financial Group lifted their price target on shares of MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 27th. Finally, StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a report on Monday, November 25th. Fourteen research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $88.62.
Get Our Latest Stock Report on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- The Great CPU Race: AMD and Intel Battle for Dominance
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- 3 REITs to Buy and Hold for the Long Term
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.